Zai Lab Limited ADR [ZLAB] stock is trading at $32.37, down -2.44%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ZLAB shares have gain 17.75% over the last week, with a monthly amount glided 43.23%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Zai Lab Limited ADR [NASDAQ: ZLAB] stock has seen the most recent analyst activity on December 14, 2023, when Morgan Stanley initiated its Overweight rating and assigned the stock a price target of $47.50. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on August 10, 2023, and set its price target to $70. On January 21, 2022, Macquarie initiated with a Outperform rating and assigned a price target of $64 on the stock. Bernstein started tracking the stock assigning a Mkt Perform rating. Goldman initiated its recommendation with a Buy. Guggenheim started tracking with a Buy rating for this stock on April 15, 2020, and assigned it a price target of $75. In a note dated July 12, 2019, BofA/Merrill initiated an Buy rating.
Zai Lab Limited ADR [ZLAB] stock has fluctuated between $13.48 and $36.60 over the past year. Currently, Wall Street analysts expect the stock to reach $75.5 within the next 12 months. Zai Lab Limited ADR [NASDAQ: ZLAB] shares were valued at $32.37 at the most recent close of the market. An investor can expect a potential return of 133.24% based on the average ZLAB price forecast.
Analyzing the ZLAB fundamentals
Zai Lab Limited ADR [NASDAQ:ZLAB] reported sales of 322.71M for the trailing twelve months, which represents a growth of 45.95%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -1.1%, Pretax Profit Margin comes in at -0.92%, and Net Profit Margin reading is -0.92%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.38 and Total Capital is -0.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 31.53 points at the first support level, and at 30.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.19, and for the 2nd resistance point, it is at 34.02.
Ratios To Look Out For
For context, Zai Lab Limited ADR’s Current Ratio is 3.46. Also, the Quick Ratio is 3.29, while the Cash Ratio stands at 2.9. Considering the valuation of this stock, the price to sales ratio is 9.94, the price to book ratio is 4.51.
Transactions by insiders
Recent insider trading involved Chen Yajing, Chief Financial Officer, that happened on Oct 02 ’24 when 301.0 shares were sold. Officer, Chen Yajing completed a deal on Oct 02 ’24 to buy 301.0 shares. Meanwhile, Former Officer Reinhart Harald bought 60000.0 shares on Sep 26 ’24.
